• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
SUN Weiqiang,XU Limin,WEN Dianmin,BI Xiaojie,RONG Lingyan,MU Shaoxia,YU Dapeng.Research progress on pharmacological effects of Salvia miltiorrhiza in orthopedic diseases[J].Journal Of Pharmaceutical Research,2026,45(7):806-811[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 991times   Download 569次 QR Code for this article
Scan with your phone!
丹参在骨科疾病中的药理作用研究进展
孙卫强1,徐立民1,温佃敏2,毕晓杰1,荣凌燕1,牟绍霞1,于大鹏1
Font:Larger+|Default|Smaller-
(1.山东省文登整骨医院,山东 威海 264499;2.威海市卫生学校,山东 威海 264400)
摘要:
丹参是重要的传统中药,活性成分丰富,在中医骨伤的治疗中有重要药用价值,本文综述了丹参及其主要活性成分(丹参酮、丹参素、丹酚酸等)在骨骼关节修复、神经保护及术后并发症防治方面的研究进展。其作用机制涵盖多靶点、多通路调控:通过激活磷脂酰肌醇3-激酶/蛋白激酶B(PI3K/Ak1)、转化生长因子-B(TGF-B)/Smad等信号通路促进成骨、抑制破骨,从而改善骨密度、加速骨折愈合;通过抑制核因子kB(NF-kB)等炎症通路减轻关节炎症;同时通过改善微循环、抗氧化应激及抗凋亡作用促进神经功能重建,并有效预防肌腱黏连及深静脉血栓。尽管前景广阔,但丹参成分复杂、脂溶性成分生物利用度低等问题仍待解决。未来研究应聚焦于阐明其协同作用机制,开发新型递送系统,并开展高质量临床循证研究,以推动其在骨科精准治疗中的应用。
关键词:  丹参  骨科  药理作用  作用机制
DOI:10.13506/j.cnki.jpr.2026.07.013
基金项目:山东省医药卫生科技发展计划项目(No.2019WS219);威海市中医药科技项目(No.2022N-39、2022Ⅱ-6、2023Ⅲ-20)
Received Date:December 17, 2025   Revision Date:January 19, 2026   Publication Date:July 31, 2026
Research progress on pharmacological effects of Salvia miltiorrhiza in orthopedic diseases
SUN Weiqiang1,XU Limin1,WEN Dianmin2,BI Xiaojie1,RONG Lingyan1,MU Shaoxia1,YU Dapeng1
(1.Wendeng Orthopedic Hospital of Shandong Province, Weihai 264499, China;2. Weihai Health School, Weihai 264400, China)
Abstract:
Salvia miltiorrhiza is a valuable traditional Chinese medicine with abundant active ingredients and important medicinal value in the treatment of orthopedic diseases. This paper systematically reviews the research progress of Salvia miltiorrhiza and its main active components (tanshinones, danshensu, salvianolic acids, ete.) in skeletal and articulartepair, neuroprotection, and prevention and treatnent of postoperative complications. Its pharmacological mechanisms involvemulti-target and muli-pathway regulation.Specifically,it activates PI3K/Akt, TGF-B/Smad and other signaling pathways topromote osteogenesis and inhibit osteoclastogenesis, thereby improving bone mineral density and accelerating fracturehealing.It also suppreses inflammatory responses by inhibiting the NF-kB signaling pathway to alleviate joint inflammation.In addition,it improves microcirculation, exerts anti-oxidative and anti-apoptotic effects to facilitate neurological functionareconstruction, and effectively prevents tendon adhesion and deep vein thrombosis. Although Salvia miltiorhiza posessesbroad application prospects, several problems remain to be resolved, including its complex composition and the lowbioavailability of lipophilic components. Future studies should focus on clarifying its synergistic mechanisms, developing novel drug delivery systems, and conducting high-quality clinical evidence-based research to promote its precise clinical application in orthopedics.
Key words:  Salvia miltiorrhiza  Orthopedics  Pharmacological effects  Mechanism of Action
Today's Visits:487    Total Visits:2383201
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.